December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

49.46 -0.58 (-1.16%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,020,894
Open 48.78
Bid (Size) 49.60 (1)
Ask (Size) 49.66 (3)
Prev. Close 50.04
Today's Range 48.49 - 49.47
52wk Range 45.05 - 113.02
Shares Outstanding N/A
Dividend Yield 4.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal
Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company. 
Via Investor's Business Daily
Topics Law Enforcement Lawsuit
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism. 
Via Stocktwits

Performance

YTD
-43.5%
-43.5%
1 Month
-16.4%
-16.4%
3 Month
+2.6%
+2.6%
6 Month
-28.6%
-28.6%
1 Year
-55.8%
-55.8%

More News

Read More
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Via Benzinga
Topics ETFs
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer
Via Stocktwits
P/E Ratio Insights for Novo Nordisk
Via Benzinga
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Via Investor's Business Daily
Topics Economy Government
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Via Benzinga
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner
Via The Motley Fool
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?
Via The Motley Fool
Topics Government Intellectual Property
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
Via The Motley Fool
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
What Is 1 of the Best Pharmaceutical Stocks to Buy Now?
Via The Motley Fool
Viking Therapeutics: High Risk, High Reward Play
Via MarketBeat
Options Corner: A Reliable Quant Signal Just Flashed Again For Pharma Giant Novo Nordisk
Via Benzinga
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
Via Benzinga
Topics Initial Public Offering
Breakout Momentum Plays You Need to Know About
Via MarketBeat
Weight Loss Drugs Are Quietly Exploding Employer Health Insurance Costs: 'There Is A Quiet Alarm Bell Going Off'
Via Benzinga
Marjorie Taylor Greene Buys 6 Stocks And Bitcoin ETF: Here's Her Latest Shopping List
Via Benzinga
Novo Nordisk Shares Tumble Amid Sweeping Board Overhaul
Via MarketMinute
Topics Economy Government Intellectual Property
3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report
Via The Motley Fool
Topics Intellectual Property
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Via The Motley Fool
Topics Government
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Via The Motley Fool
Behind the Scenes of Novo Nordisk's Latest Options Trends
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 49.46
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/31/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.